BNGO (STOCKS)
Bionano Genomics, Inc. Common Stock
$1.130000
+0.040000 (+3.67%)
Prev close: $1.090000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Robert Erik Holmlin
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $11.09M
- Employees
- 100
- P/E (TTM)
- -0.07
- P/B (TTM)
- 0.03
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
2
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2025 (Q3)
|
$-1.59 | $-1.95 | +0.3582 | +18.39% |
|
Jun 2025 (Q2)
|
$-1.99 | $-2.46 | +0.4733 | +19.21% |
|
Mar 2025 (Q1)
|
$-1.15 | $-3.08 | +1.9328 | +62.68% |
|
Dec 2024 (Q4)
|
$-15.83 | $-6.12 | -9.7100 | -158.66% |
Financial Statements
| Revenues | $28.72M |
| Benefits Costs and Expenses | $67.27M |
| Cost Of Revenue | $15.52M |
| Costs And Expenses | $49.95M |
| Gross Profit | $13.20M |
| Nonoperating Income/Loss | -$1.81M |
| Operating Expenses | $49.95M |
| Selling, General, and Administrative Expenses | $38.19M |
| Research and Development | $11.62M |
| Operating Income/Loss | -$36.74M |
| Income/Loss From Continuing Operations After Tax | -$38.59M |
| Income/Loss From Continuing Operations Before Tax | -$38.55M |
| Income Tax Expense/Benefit | $33.00K |
| Net Income/Loss | -$38.59M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$38.59M |
| Net Income/Loss Available To Common Stockholders, Basic | -$38.59M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$12.77 |
| Diluted Earnings Per Share | -$12.77 |
| Basic Average Shares | 3,954,000 |
| Diluted Average Shares | 3,954,000 |
| Assets | $79.06M |
| Current Assets | $48.80M |
| Inventory | $8.42M |
| Other Current Assets | $40.38M |
| Noncurrent Assets | $30.26M |
| Fixed Assets | $16.17M |
| Intangible Assets | $5.69M |
| Other Non-current Assets | $8.41M |
| Liabilities | $29.26M |
| Current Liabilities | $22.98M |
| Accounts Payable | $5.99M |
| Wages | $2.63M |
| Other Current Liabilities | $14.35M |
| Noncurrent Liabilities | $6.29M |
| Equity | $49.80M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $49.80M |
| Liabilities And Equity | $79.06M |
| Net Cash Flow From Operating Activities | -$18.67M |
| Net Cash Flow From Operating Activities, Continuing | -$18.67M |
| Net Cash Flow From Investing Activities | -$13.76M |
| Net Cash Flow From Investing Activities, Continuing | -$13.76M |
| Net Cash Flow From Financing Activities | $26.33M |
| Net Cash Flow From Financing Activities, Continuing | $26.33M |
| Exchange Gains/Losses | -$22.00K |
| Net Cash Flow | -$6.13M |
| Net Cash Flow, Continuing | -$6.11M |
| Comprehensive Income/Loss | -$40.12M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$40.12M |
| Other Comprehensive Income/Loss | -$40.12M |
| Other Comprehensive Income/Loss Attributable To Parent | -$1.53M |